Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 50,968,402	$ 47,752,053
Research and development credits	4,393,368	3,940,199
R&D expenditures capitalization	2,001,908	0
Deferred revenue	45,373	42,802
Inventory reserve	310,983	6,806
Fixed assets and intangibles	291,244	304,019
Lease liability	266,797	366,653
Other	755,029	711,343
Gross deferred tax assets	60,068,763	54,320,438
Valuation allowance	(59,805,688)	(53,958,617)
Deferred tax assets, net	263,075	361,821
Right of use asset	263,075	361,821
Total deferred tax liabilities	263,075	361,821
Net deferred tax assets (liabilities)	0	0
NuvoGen
Deferred tax assets:
Accrued liability	$ 1,035,659	$ 1,196,563